BAM
RNLX

Belpointe Asset Management’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Belpointe Asset Management’s Portfolio RNLX Stock Details RNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-200
Closed -$484 – 3549
2023
Q1 		$484 Hold
200
– – ﹤0.01% 3597
2022
Q4 		$374 Buy
+200
New +$312 ﹤0.01% 3576

Other funds holding RNLX

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.65B AUM 20.56% 1-Year Est. Return

Belpointe Asset Management's RNLX Position: Q2 2023 in Review

Belpointe Asset Management sold out of Renalytix plc American Depositary Shares (RNLX) in Q2 2023, closing a stake of 200 shares — an estimated $484 sold.

Belpointe Asset Management first reported a position in RNLX in Q4 2022 and held it in 2 quarters. The position peaked at $484 in Q1 2023. 19 funds tracked by Wall St. Rank hold RNLX as of Q2 2023.

  • Belpointe Asset Management reported no remaining Renalytix plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 200 Renalytix plc American Depositary Shares shares in Q2 2023, an estimated $484.
  • Belpointe Asset Management first reported a position in Renalytix plc American Depositary Shares in Q4 2022 and held it in 2 quarters.
  • Belpointe Asset Management's Renalytix plc American Depositary Shares position peaked at $484 in Q1 2023.
  • 19 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.